Kangmei Pharma | 600518 - Equity Capital And Reserves

Stock Price
1.71
Daily Change
-0.02 -1.16%
Monthly
-3.39%
Yearly
-14.07%
Q2 Forecast
1.69

Kangmei Pharma reported CNY7.22B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 32.61M 8.98M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Dianthus Therapeutics USD 493.4M 53.05M Dec/2025
Genomma Lab Internacional MXN 11.72B 603.74M Mar/2026
Hypermarcas BRL 12.52B 266.92M Dec/2025
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
IQVIA Holdings USD 6.5B 343M Dec/2025
Jiangsu Hengrui CNY 63.63B 2.35B Mar/2026
Kangmei Pharma CNY 7.22B 504.3M Sep/2025
Moderna USD 8.65B 680M Dec/2025
Organon & Co USD 906M 173M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Sh Fosun Pharma CNY 49.15B 248.15M Mar/2026
Tectonic Therapeutic USD 251.33M 16.2M Dec/2025
Viatris USD 15.22B 352.9M Sep/2025
Wuxi Apptec CNY 80.66B 9.19B Dec/2025
Xeris Pharmaceuticals USD 13.69M 14.55M Dec/2025
Zz Pientze Pharmaceu CNY 14.47B 173.2M Sep/2025